e-Therapeutics launched for Canadian Physicians and Pharmacists
Posted Oct 30 2008 3:22pm
A new Canadian 'clinical decision support program' has been launched by the Canadian Pharmacists Association. This program received signficant funding from Health Canada and incorporates the Lexi-Interact drug comparison engine and the CPS - Compendium of Pharmaceuticals and Specialties which is used extensively by physicians and pharmacists. (It is important to note that the CPS does not contain monographs of all drugs available in Canada, only those product monographs for which a fee is paid by the pharmaceutical companies). The only pharmaceutical products searched through e-Therapeutics are those that appear in the CPS. There is expressed intent to integrate the e-Therapeutics database into EMR systems, but to date this has not taken place. To read the article, see the exerpt below:
"TORONTO – Assisted by $8.8 million in development funds from Health
Canada, the Canadian Pharmacists Association has launched a web-based
medication management tool that’s designed to offer quick
decision-support at the point of care.
The CPhA calls it “a second opinion from Canadian experts on what
works, when – that you can consult anytime, anywhere.”
Dubbed e-Therapeutics, the system enables physicians, nurses,
pharmacists and other practitioners to check on various drugs, obtain
warnings about possible interactions with other medications and herbal
remedies, and view ‘best treatment’ options for a wide variety of
All of this is presented in a Canadian context, with Canadian drug
names, and advisories and alerts from Health Canada.
Care-givers can use the system through the e-Therapeutics web portal or
on handheld computers, like the Palm or Pocket PC.
Information about the service is available at www.e-therapeutics.ca It’s a subscription-based service; individuals can subscribe for $389 per year. Because it uses industry standards, the system is designed to integrate with various electronic medical record systems. However, actual integration with leading EMRs hasn’t yet been accomplished. Link: Canadian Healthcare Technology - News 357.
As a physician user of technology and/or EMR, would you subscribe to e-Therapeutics product as described? If you are a current user of Lexi Drugs or ePocrates, does this new service add additional value and warrant the subscription cost? Is it sufficient to be able to search drugs that appear in the CPS vs. all products that are available in Canada? To share your thoughts, cick on the 'Comments' link.